{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:59:41Z","timestamp":1792555181724,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jacl.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:47:48Z","timestamp":1770742068000},"page":"789-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission"],"prefix":"10.1016","volume":"20","author":[{"given":"Prachi","family":"Bajpai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-6548","authenticated-orcid":false,"given":"Mukta","family":"Mantan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-8312","authenticated-orcid":false,"given":"Akanksha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-060X","authenticated-orcid":false,"given":"Aashima","family":"Dabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9384","key":"10.1016\/j.jacl.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacl.2026.02.001_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","article-title":"Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature","volume":"26","author":"El Bakkali","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.jacl.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jacl.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0270-9295(03)00058-5","article-title":"Hyperlipidemia and thrombotic complications in patients with membranous nephropathy","volume":"23","author":"Nickolas","year":"2003","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1016\/j.jacl.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","article-title":"Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention","volume":"8","author":"Amarenco","year":"2009","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.jacl.2026.02.001_bib6","first-page":"35","article-title":"Nephrotic syndrome induced dyslipidemia in children and need for early assessment","volume":"3","author":"Biswas","year":"2017","journal-title":"J Med Dent Sci Res"},{"issue":"7","key":"10.1016\/j.jacl.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0009-9120(03)00103-6","article-title":"Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome","volume":"36","author":"Merouani","year":"2003","journal-title":"Clin Biochem"},{"issue":"1-2","key":"10.1016\/j.jacl.2026.02.001_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20452\/pamw.592","article-title":"Is dyslipidemia sustained during remission of nephrotic syndrome genetically determined? Evaluation of genetic polymorphisms of proteins involved in lipoprotein metabolism in children and adolescents with nephrotic syndrome","volume":"119","author":"Ksiazek","year":"2009","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"10.1016\/j.jacl.2026.02.001_bib9","first-page":"57","article-title":"Lipoprotein (a) and other dyslipidemia in Saudi children with nephrotic syndrome (SSNS and SRNS)","volume":"2","author":"Kari","year":"2012","journal-title":"J Health Sci"},{"issue":"5","key":"10.1016\/j.jacl.2026.02.001_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","article-title":"Steroid-sensitive nephrotic syndrome: revised guidelines","volume":"58","author":"Sinha","year":"2021","journal-title":"Indian Pediatr"},{"issue":"7","key":"10.1016\/j.jacl.2026.02.001_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s13312-021-2262-y","article-title":"Consensus guidelines on management of steroid-resistant nephrotic syndrome","volume":"58","author":"Vasudevan","year":"2021","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jacl.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13312-015-0566-5","article-title":"Revised IAP growth charts for height, weight, and body mass index for 5\u201318-year-old children","volume":"52","author":"Khadilkar","year":"2015","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jacl.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.jacl.2026.02.001_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2096","article-title":"Diagnosis, evaluation, and management of high blood pressure in children and adolescents","volume":"142","author":"Baker-Smith","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.89.3.495","article-title":"National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents","volume":"89","author":"NCEP Expert Panel of Blood Cholesterol Levels in Children and Adolescents","year":"1992","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jacl.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s43044-021-00150-z","article-title":"The relation between ApoB\/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome","volume":"73","author":"Yaseen","year":"2021","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.jacl.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-511X-13-81","article-title":"The value of Apolipoprotein B\/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study","volume":"13","author":"Jing","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s10157-018-1565-3","article-title":"Hypertension and its severity in children with steroid-sensitive nephrotic syndrome during remission","volume":"22","author":"Keshri","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacl.2026.02.001_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.09.010","article-title":"Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects","volume":"19","author":"A Kostapanos","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacl.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-019-1144-y","article-title":"Comparison of apolipoprotein B\/A1 ratio, Framingham risk score and TC\/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention","volume":"18","author":"Tian","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5694\/j.1326-5377.1998.tb126712.x","article-title":"Apolipoprotein screening in Australian children: feasibility and the effect of age, sex, and ethnicity","volume":"168","author":"Lynch","year":"1998","journal-title":"Med J Aust"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:02:23Z","timestamp":1776427343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1933287426000279"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.02.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}